Jürgen Frisch

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 784 citations

Medicine, Immunology, Oncology +17

Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

Axel Le Cesne, Ian Judson, D. Crowther et al. · Journal of Clinical Oncology · 2000 · 258 citations

Medicine, Oncology, Pharmacology +15

Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure

A Ganser, A Lindemann, G Seipelt et al. · Blood · 1990 · 234 citations · Full text

Life Sciences, Hematology, Immunology +16

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]

W Brugger, K. Bross, Jürgen Frisch et al. · Blood · 1992 · 212 citations · Full text

Medicine, Hematology, Oncology +14

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.

William P. Steward, Joachim von Pawel, U. Gatzemeier et al. · Journal of Clinical Oncology · 1998 · 147 citations

Medicine, Oncology, Pharmacology +16